Podcast appearances and mentions of gerard silvestri

  • 11PODCASTS
  • 39EPISODES
  • 9mAVG DURATION
  • ?INFREQUENT EPISODES
  • Nov 18, 2021LATEST

POPULARITY

20172018201920202021202220232024


Best podcasts about gerard silvestri

Latest podcast episodes about gerard silvestri

Pleural Space | Conversations in Lung Cancer
Mythbusting LCS in Pulmonology: Role of the Pulmonologist (Part 1)

Pleural Space | Conversations in Lung Cancer

Play Episode Listen Later Nov 18, 2021 7:49


*This episode was originally part of the ACR Bulletin podcast and was recorded in 2020. To get the pulmonologist perspective of lung cancer screening, Dr. Debra Dyer, MD, speaks with Dr. Gerard Silvestri, MD, about what the role of the pulmonologist is in lung cancer screening in the first episode of this five-part conversation. As part of National Lung Cancer Awareness Month 2020, Dr. Debra Dyer, Chair of the ACR's Lung Cancer Screening Steering Committee, had a series of conversations with stakeholders across the healthcare spectrum about myths in lung screening in the limited series “Mythbusting Lung Cancer Screening.” Dr. Gerard Silvestri is a lung cancer pulmonologist at the Medical University of South Carolina. He has served on the Data and Safety Monitoring Board of the national Prostate, Lung, Colorectal and Ovarian screening trial, representing the lung arm of the trial. Dr. Silvestri participates as a Steering Committee member and Task Group Chair on the American Cancer Society's National Lung Cancer Screening Roundtable Steering Committee. Additional information on this topic, as well as the resources mentioned during the episode, can be found at https://www.acr.org/Clinical-Resources/Lung-Cancer-Screening-Resources.

Pleural Space | Conversations in Lung Cancer
Mythbusting LCS in Pulmonology: Patient Expectations Regarding Tobacco Treatment (Part 2)

Pleural Space | Conversations in Lung Cancer

Play Episode Listen Later Nov 18, 2021 8:11


*This episode was originally part of the ACR Bulletin podcast and was recorded in 2020. Dr. Debra Dyer, MD, continues her conversation with Dr. Gerard Silvestri, MD, about what a patient can expect regarding tobacco treatment in the context of lung cancer screening in part two of this five-part conversation. As part of National Lung Cancer Awareness Month 2020, Dr. Debra Dyer, Chair of the ACR's Lung Cancer Screening Steering Committee, had a series of conversations with stakeholders across the healthcare spectrum about myths in lung screening in the limited series “Mythbusting Lung Cancer Screening.” Dr. Gerard Silvestri is a lung cancer pulmonologist at the Medical University of South Carolina. He has served on the Data and Safety Monitoring Board of the national Prostate, Lung, Colorectal and Ovarian screening trial, representing the lung arm of the trial. Dr. Silvestri participates as a Steering Committee member and Task Group Chair on the American Cancer Society's National Lung Cancer Screening Roundtable Steering Committee. Additional information on this topic, as well as the resources mentioned during the episode, can be found at https://www.acr.org/Clinical-Resources/Lung-Cancer-Screening-Resources.

Pleural Space | Conversations in Lung Cancer
Mythbusting LCS in Pulmonology: Abnormal Exams (Part 3)

Pleural Space | Conversations in Lung Cancer

Play Episode Listen Later Nov 18, 2021 10:02


*This episode was originally part of the ACR Bulletin podcast and was recorded in 2020. In part three of their five-part conversation, Dr. Debra Dyer, MD, and Dr. Gerard Silvestri, MD, discuss what a patient should expect if their lung cancer screening CT exam is abnormal. As part of National Lung Cancer Awareness Month 2020, Dr. Debra Dyer, Chair of the ACR's Lung Cancer Screening Steering Committee, had a series of conversations with stakeholders across the healthcare spectrum about myths in lung screening in the limited series “Mythbusting Lung Cancer Screening.” Dr. Gerard Silvestri is a lung cancer pulmonologist at the Medical University of South Carolina. He has served on the Data and Safety Monitoring Board of the national Prostate, Lung, Colorectal and Ovarian screening trial, representing the lung arm of the trial. Dr. Silvestri participates as a Steering Committee member and Task Group Chair on the American Cancer Society's National Lung Cancer Screening Roundtable Steering Committee. Additional information on this topic, as well as the resources mentioned during the episode, can be found at https://www.acr.org/Clinical-Resources/Lung-Cancer-Screening-Resources.

Pleural Space | Conversations in Lung Cancer
Mythbusting LCS in Pulmonology: Adhering to Screening Protocol Annually (Part 4)

Pleural Space | Conversations in Lung Cancer

Play Episode Listen Later Nov 18, 2021 8:25


*This episode was originally part of the ACR Bulletin podcast and was recorded in 2020. Dr. Debra Dyer, MD, continues her conversation with Dr. Gerard Silvestri, MD, about the importance of adhering to the screening protocol annually to achieve full benefit in the fourth installment in their five-part discussion. As part of National Lung Cancer Awareness Month 2020, Dr. Debra Dyer, Chair of the ACR's Lung Cancer Screening Steering Committee, had a series of conversations with stakeholders across the healthcare spectrum about myths in lung screening in the limited series “Mythbusting Lung Cancer Screening.” Dr. Gerard Silvestri is a lung cancer pulmonologist at the Medical University of South Carolina. He has served on the Data and Safety Monitoring Board of the national Prostate, Lung, Colorectal and Ovarian screening trial, representing the lung arm of the trial. Dr. Silvestri participates as a Steering Committee member and Task Group Chair on the American Cancer Society's National Lung Cancer Screening Roundtable Steering Committee. Additional information on this topic, as well as the resources mentioned during the episode, can be found at https://www.acr.org/Clinical-Resources/Lung-Cancer-Screening-Resources.

Pleural Space | Conversations in Lung Cancer
Mythbusting LCS in Pulmonology: The National Lung Cancer Roundtable (Part 5)

Pleural Space | Conversations in Lung Cancer

Play Episode Listen Later Nov 18, 2021 13:50


*This episode was originally part of the ACR Bulletin podcast and was recorded in 2020. In the final part of their five-part conversation, Dr. Debra Dyer, MD, and Dr. Gerard Silvestri, MD, showcase the National Lung Cancer Roundtable's (NLCRT) work with member organizations to advance efforts to promote lung cancer screening. As part of National Lung Cancer Awareness Month 2020, Dr. Debra Dyer, Chair of the ACR's Lung Cancer Screening Steering Committee, had a series of conversations with stakeholders across the healthcare spectrum about myths in lung screening in the limited series “Mythbusting Lung Cancer Screening.” Dr. Gerard Silvestri is a lung cancer pulmonologist at the Medical University of South Carolina. He has served on the Data and Safety Monitoring Board of the national Prostate, Lung, Colorectal and Ovarian screening trial, representing the lung arm of the trial. Dr. Silvestri participates as a Steering Committee member and Task Group Chair on the American Cancer Society's National Lung Cancer Screening Roundtable Steering Committee. Additional information on this topic, as well as the resources mentioned during the episode, can be found at https://www.acr.org/Clinical-Resources/Lung-Cancer-Screening-Resources.

CHEST Journal Podcasts
Screening for Lung Cancer: CHEST Guideline and Expert Panel Report

CHEST Journal Podcasts

Play Episode Listen Later Sep 22, 2021 61:20


Join moderators Alice Gallo de Moraes, MD, and Vineesha Arelli, MD, and journal CHEST® authors Peter Mazzone, MD, MPH, FCCP, and Gerard Silvestri, MD, MS, as they discuss the article, "Screening for Lung Cancer: CHEST Guideline and Expert Panel Report – Executive Summary," which was published in the September issue. DOI: https://doi.org/10.1016/j.chest.2021.06.063

Public Health On Call
Bonus - The Promise and Perils of the Lung Cancer Screening Tool: Tradeoff's Dan Gorenstein Talks to Experts and Patients About Early Detection Vs Unnecessary Treatments

Public Health On Call

Play Episode Listen Later Jul 1, 2021 26:30


On a special episode, Tradeoffs host Dan Gorenstein talks with a host of experts about screening for lung cancer, America's number one cancer killer. While CT scans have provided early insights into a cancer that previously wasn't caught until far too late, this tool has also led to unnecessary procedures, costs, and even disability and death for patients that may not have even been sick. You'll hear from pulmonologist Dr. Gerard Silvestri; behavioral scientist and nurse practitioner Dr. Lisa Carter-Harris; Dr. Cherie Erkmen, surgeon and director of Temple University's Lung Cancer Screening Program; Johns Hopkins oncologist Dr. Otis Brawley; Ida Pittman, a lung cancer patient, and Helena Price, her cousin and health care advocate. If you like this episode, check out the Tradeoffs' podcast www.tradeoffs.org

Deep Breaths: Updates from CHEST
The Role of Tissue Acquisition in Diagnosing Non-Small Cell Lung Cancer

Deep Breaths: Updates from CHEST

Play Episode Listen Later May 25, 2021


Host: Gerard A. Silvestri MD, MS, FCCP Guest: Michael S. Machuzak, MD Clinicians can uncover a wealth of information from a non-small cell lung cancer patient's collected tissue that can help inform treatment decisions. To dive into this idea further, Dr. Gerard Silvestri is joined by his colleague Dr. Michael Machuzak, Full Staff Member in the Department of Pulmonary, Allergy, and Critical Care Medicine at Cleveland Clinic. Together they review the importance of tissue acquisition, proper handling of specimens, rapid onsite evaluation during EBUS-TBNA procedures, and much more.An educational campaign brought to you by CHEST, in collaboration with AstraZeneca.

Deep Breaths: Updates from CHEST
Pulmonary Toxicities Related to Cancer Treatment

Deep Breaths: Updates from CHEST

Play Episode Listen Later May 25, 2021


Host: Gerard A. Silvestri MD, MS, FCCP Guest: Lynn Tanoue, MD, MBA About 10 percent of all cancer patients develop treatment-related pulmonary complications, and for lung cancer patients, that risk is even greater. Dr. Gerard Silvestri sits down with Dr. Lynn Tanoue, Professor of Medicine and Vice Chair of Clinical Affairs in the section of pulmonary critical care and sleep medicine at the Yale Cancer Center in New Haven, Connecticut, to discuss pulmonary toxicities related to lung cancer treatment.An educational campaign brought to you by CHEST, in collaboration with AstraZeneca.

A Health Podyssey
Lowering Medicare eligibility may improve cancer outcomes

A Health Podyssey

Play Episode Listen Later May 18, 2021 24:38


"I think we need to step back first before we even ask the policy question and ask this simple question, is it okay in the United States to die of cancer simply because you don't have health insurance?" - Dr. Gerard SilvestriCancer is a leading cause of death in the United States. Although there have been declines in cancer deaths in recent years, improvements have not been equally distributed across the population.The risk of cancer increases with age and nearly a quarter of all new cancers diagnosed each year in the US occur among those aged 55 to 64 years old. At age 65, most Americans gain Medicare coverage, creating a ready comparison of cancer outcomes between those just below age 65 — who may have private insurance, Medicaid, or are uninsured — and those above 65 who are on Medicare.The relationship between insurance coverage and cancer outcomes is the subject of this episode of A Health Podyssey.  Dr. Gerard Silvestri, a professor of thoracic oncology at the Medical University of South Carolina, joins the program to discuss a paper he and co-authors published in the May 2021 issue of Health Affairs wherein they found significantly worse survival rates for uninsured patients ages 60 to 64 in comparison to Medicare beneficiaries.Listen to Alan Weil interview Gerard Silvestri on cancer outcomes among Medicare beneficiaries and their younger, uninsured counterparts.Subscribe: RSS | Apple Podcasts | Spotify | Stitcher | Google Podcasts

The ACR Bulletin Podcast
The ACR Bulletin Podcast Season 2 Episode 2 Part 1: Role of the Pulmonologist with Gerard Silvestri, MD

The ACR Bulletin Podcast

Play Episode Listen Later Nov 13, 2020 7:49


Debra Dyer, MD, Chair of the Lung Cancer Screening Steering committee has a conversation with Dr. Gerard Silvestri about what the role of the pulmonologist is in lung cancer screening.

The ACR Bulletin Podcast
The ACR Bulletin Podcast Season 2 Episode 2 Part 2: Patient expectations regarding tobacco treatment with Gerard Silvestri, MD

The ACR Bulletin Podcast

Play Episode Listen Later Nov 13, 2020 8:11


Debra Dyer, MD, Chair of the Lung Cancer Screening Steering committee has a conversation with Gerard Silvestri, MD about what a patient can expect regarding tobacco treatment in the context of lung cancer screening.

The ACR Bulletin Podcast
The ACR Bulletin Podcast Season 2 Episode 2 Part 3: Abnormal Exams with Gerard Silvestri, MD

The ACR Bulletin Podcast

Play Episode Listen Later Nov 13, 2020 10:02


Debra Dyer, MD, Chair of the Lung Cancer Screening Steering committee has a conversation with Dr. Gerard Silvestri, MD about what a patient should expect if their lung cancer screening CT exam is abnormal.

The ACR Bulletin Podcast
The ACR Bulletin Podcast Season 2 Episode 2 Part 4: Adhering to screening protocol annually with Gerard Silvestri, MD

The ACR Bulletin Podcast

Play Episode Listen Later Nov 13, 2020 8:25


Debra Dyer, MD, Chair of the Lung Cancer Screening Steering committee has a conversation with Dr. Gerard Silvestri about the importance of adhering to the screening protocol annually in order to achieve full benefit.

The ACR Bulletin Podcast
The ACR Bulletin Podcast Season 2 Episode 2 Part 5: The National Lung Cancer Roundtable with Gerard Silvestri,

The ACR Bulletin Podcast

Play Episode Listen Later Nov 13, 2020 13:50


Debra Dyer, MD, Chair of the Lung Cancer Screening Steering committee has a conversation with Dr. Gerard Silvestri about the National Lung Cancer Roundtables work with member organizations to advance efforts to promote lung cancer screening.

national md bulletin gerard silvestri lung cancer roundtable
ACS Research - TheoryLab
Reasons for hope in the fight against lung cancer

ACS Research - TheoryLab

Play Episode Listen Later Nov 13, 2019 31:00


As a lung cancer pulmonologist who sees 5-7 new patients every week, runs a patient-focused clinical research program, and has been helping patients fight lung cancer for more than 25 years, Gerard Silvestri, MD, MS, has a long history with this disease. So when he says, “I have never been in my career so optimistic as I am now,” take note. In this interview Dr. Silvestri talks about reasons for optimism in nearly every aspect of lung cancer research, from prevention and screening to new treatments and survivorship. Dr. Silvestri is Professor of Medicine and the George C. and Margaret M. Hillenbrand Endowed Chair at the Medical University of South Carolina. He’s also on the steering committee of the National Lung Cancer Roundtable, a coalition of leading professional, government and non-governmental organizations working to accelerate the nation's efforts to reduce mortality from lung cancer. 2:29 – On his work in the clinic and the lab: “Every Tuesday I see between 5 and 7 new patients with lumps and bumps, and my job is to do three things—ask the questions: ‘What is it?’ (that’s the diagnosis); ‘Where is it?’ (that’s the stage); and ‘What can we do about it?’ (those are the treatment options).” 4:21 – What should people know about lung cancer? After noting that, “more women will die of lung cancer than all other female cancers combined,” he shared encouraging news about prevention and screening. 6:36 – On what it means to be a high-risk patient 8:42 – On where high-risk patients should go for screening, and the importance of returning for follow-up screenings: “The where is actually really important…you should be in a place that can really care for you.” 12:11 – On lung cancer in patients who have never smoked 15:09 – On why he’s never been more optimistic about treatment breakthroughs 20:04 – On the work of the National Lung Cancer Roundtable 23:30 – On three aspects of the Roundtable’s work that are particularly exciting 27:51 – A message he’d like to share with cancer patients and caregivers

GRACEcast ALL Subjects audio and video
The Basics of a Lung Cancer Workup

GRACEcast ALL Subjects audio and video

Play Episode Listen Later Mar 1, 2016 4:27


Dr. Gerard Silvestri, Medical University of South Carolina, describes the steps necessary to work up a lung cancer diagnosis, from initial scan to choice of treatment.

GRACEcast
The Basics of a Lung Cancer Workup

GRACEcast

Play Episode Listen Later Mar 1, 2016 4:27


Dr. Gerard Silvestri, Medical University of South Carolina, describes the steps necessary to work up a lung cancer diagnosis, from initial scan to choice of treatment.

GRACEcast Lung Cancer Video
The Basics of a Lung Cancer Workup

GRACEcast Lung Cancer Video

Play Episode Listen Later Mar 1, 2016 4:27


Dr. Gerard Silvestri, Medical University of South Carolina, describes the steps necessary to work up a lung cancer diagnosis, from initial scan to choice of treatment.

GRACEcast ALL Subjects audio and video
What Are Pulmonary Function Tests, and How Are They Used?

GRACEcast ALL Subjects audio and video

Play Episode Listen Later Feb 29, 2016 2:48


Dr. Gerard Silvestri, Medical University of South Carolina, defines pulmonary function testing, and describes how lung cancer surgeons use them.

GRACEcast
What Are Pulmonary Function Tests, and How Are They Used?

GRACEcast

Play Episode Listen Later Feb 29, 2016 2:48


Dr. Gerard Silvestri, Medical University of South Carolina, defines pulmonary function testing, and describes how lung cancer surgeons use them.

GRACEcast Lung Cancer Video
What Are Pulmonary Function Tests, and How Are They Used?

GRACEcast Lung Cancer Video

Play Episode Listen Later Feb 29, 2016 2:48


Dr. Gerard Silvestri, Medical University of South Carolina, defines pulmonary function testing, and describes how lung cancer surgeons use them.

GRACEcast ALL Subjects audio and video
PET Scan Imaging: What Does It Tell Us?

GRACEcast ALL Subjects audio and video

Play Episode Listen Later Feb 28, 2016 1:58


Dr. Gerard Silvestri, Medical University of South Carolina, discusses the use of PET scans in lung cancer workup.

GRACEcast
PET Scan Imaging: What Does It Tell Us?

GRACEcast

Play Episode Listen Later Feb 28, 2016 1:58


Dr. Gerard Silvestri, Medical University of South Carolina, discusses the use of PET scans in lung cancer workup.

GRACEcast Lung Cancer Video
PET Scan Imaging: What Does It Tell Us?

GRACEcast Lung Cancer Video

Play Episode Listen Later Feb 28, 2016 1:58


Dr. Gerard Silvestri, Medical University of South Carolina, discusses the use of PET scans in lung cancer workup.

GRACEcast
How a Diagnosis of Lung Cancer is Made: The Biopsy

GRACEcast

Play Episode Listen Later Feb 24, 2016 1:41


Dr. Gerard Silvestri, Medical University of South Carolina, describes several procedures used to obtain biopsy tissue in order to diagnose lung cancer.

GRACEcast Lung Cancer Video
How a Diagnosis of Lung Cancer is Made: The Biopsy

GRACEcast Lung Cancer Video

Play Episode Listen Later Feb 24, 2016 1:41


Dr. Gerard Silvestri, Medical University of South Carolina, describes several procedures used to obtain biopsy tissue in order to diagnose lung cancer.

GRACEcast ALL Subjects audio and video
How a Diagnosis of Lung Cancer is Made: The Biopsy

GRACEcast ALL Subjects audio and video

Play Episode Listen Later Feb 24, 2016 1:41


Dr. Gerard Silvestri, Medical University of South Carolina, describes several procedures used to obtain biopsy tissue in order to diagnose lung cancer.

GRACEcast
Potential Advantages, Disadvantages and Limitations of Lung Cancer Screening

GRACEcast

Play Episode Listen Later Feb 23, 2016 2:52


GRACEcast Lung Cancer Video
Potential Advantages, Disadvantages and Limitations of Lung Cancer Screening

GRACEcast Lung Cancer Video

Play Episode Listen Later Feb 23, 2016 2:52


GRACEcast ALL Subjects audio and video
Potential Advantages, Disadvantages and Limitations of Lung Cancer Screening

GRACEcast ALL Subjects audio and video

Play Episode Listen Later Feb 23, 2016 2:52


GRACEcast
Detecting Lung Cancer: Presenting Symptoms

GRACEcast

Play Episode Listen Later Feb 22, 2016 1:07


Dr. Gerard Silvestri, Medical University of South Carolina, describes some of the typical presenting symptoms of lung cancer.

GRACEcast ALL Subjects audio and video
Detecting Lung Cancer: Presenting Symptoms

GRACEcast ALL Subjects audio and video

Play Episode Listen Later Feb 22, 2016 1:07


Dr. Gerard Silvestri, Medical University of South Carolina, describes some of the typical presenting symptoms of lung cancer.

GRACEcast Lung Cancer Video
Detecting Lung Cancer: Presenting Symptoms

GRACEcast Lung Cancer Video

Play Episode Listen Later Feb 22, 2016 1:07


Dr. Gerard Silvestri, Medical University of South Carolina, describes some of the typical presenting symptoms of lung cancer.

GRACEcast Lung Cancer Video
Managing Pulmonary Complications of Lung Cancer Treatment: Targeted Therapy and Radiation-Induced Lung Damage (video)

GRACEcast Lung Cancer Video

Play Episode Listen Later Oct 25, 2012 14:20


Dr. Gerard Silvestri, pulmonologist from Medical University of South Carolina (MUSC) in Charleston, reviews the subject of pneumonitis (inflamation of the lung tissue) induced by EGFR inhibitors or chest radiation.

GRACEcast Lung Cancer Audio
Managing Pulmonary Complications of Lung Cancer Treatment: Targeted Therapy and Radiation-Induced Lung Damage (audio)

GRACEcast Lung Cancer Audio

Play Episode Listen Later Oct 24, 2012 14:19


Dr. Gerard Silvestri, pulmonologist from Medical University of South Carolina (MUSC) in Charleston, reviews the subject of pneumonitis (inflamation of the lung tissue) induced by EGFR inhibitors or chest radiation.

GRACEcast Lung Cancer Video
Managing Pulmonary Complications of Lung Cancer Treatment: Chemo-Induced Lung Damage (Video)

GRACEcast Lung Cancer Video

Play Episode Listen Later Oct 15, 2012 17:24


Dr. Gerard Silvestri, pulmonologist from Medical University of South Carolina (MUSC) in Charleston, reviews the subject of pneumonitis (inflamation of the lung tissue) induced by chemotherapy commonly used for treating lung cancer.

GRACEcast Lung Cancer Audio
Managing Pulmonary Complications of Lung Cancer Treatment: Chemo-Induced Lung Damage (Audio)

GRACEcast Lung Cancer Audio

Play Episode Listen Later Oct 14, 2012 17:24


Dr. Gerard Silvestri, pulmonologist from Medical University of South Carolina (MUSC) in Charleston, reviews the subject of pneumonitis (inflamation of the lung tissue) induced by chemotherapy commonly used for treating lung cancer.

GRACEcast Lung Cancer Audio
Diagnosis and Staging of Lung Cancer: A Pulmonologist's Perspective (audio)

GRACEcast Lung Cancer Audio

Play Episode Listen Later Oct 16, 2009 15:08


This slide presentation by Dr. Gerard Silvestri, pulmonologist at Medical Univ. of South Carolina, covers the key methods of evaluating a new lung cancer, including initial diagnosis and staging studies.